Histone acetylation-mediated regulation of genes in leukaemic cells

European Journal of Cancer

Volumn 39, Issue 8, 2003, Pages 1165-1175

  Chambers, A E ^a,c   Banerjee, S ^b   Chaplin, T ^a   Dunne, J ^a   Debernardi, S ^a   Joel, S P ^a   Young, B D ^a  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Acetylation; Gene; Histone; Leukaemia; Microarrays; Regulation

Indexed keywords

HISTONE DEACETYLASE; HISTONE DEACETYLASE INHIBITOR; OLIGONUCLEOTIDE; TRANS ACTING FACTOR; TRICHOSTATIN A;

ACETYLATION; ARTICLE; CONTROLLED STUDY; DNA MICROARRAY; ENZYME INHIBITION; GENE EXPRESSION REGULATION; GENETIC ANALYSIS; GENOME; HUMAN; HUMAN CELL; LEUKEMIA; LEUKEMIA CELL; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRADER WILLI SYNDROME; PRIORITY JOURNAL; TUMOR REGRESSION;

EID: 0038740851     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(03)00072-8     Document Type: Article

References (31)

1. Kuo M.-H., Allis C.D. Roles of histone acetyltransferases and deacetylases in gene regulation. BioEssays. 20:1998;615-626.
2. Gray S.G., Ekstrom T.J. The human histone deacetylase family. Exp. Cell Res. 262:2001;75-83.
3. Pandolfi P.P. Transcription therapy for cancer. Oncogene. 20:2001;3116-3127.
4. Minucci S., Nervi C., Lo Coco F., Pelicci P.G. Histone deacetylases. a common molecular target for differentiation treatment of acute myeloid leukemias? Oncogene. 20:2001;3110-3115.
5. Lin R.J., Nagy L., Inoue S., Shao W., Miller W.H. Jr., Evans R.M. Role of the histone deacetylase complex in acute promyelocytic leukaemia. Nature. 391:1998;811-814.
6. Saunders N., Dicker A., Popa C., Jones S., Dahler A. Histone deacetylase inhibitors as potential anti-skin cancer agents. Cancer Res. 59:1999;399-404.
7. Glick R.D., Swendeman S.L., Coffey D.C.et al. Hybrid polar histone deacetylase inhibitor induces apoptosis and CD95/CD95 ligand expression in human neuroblastoma. Cancer Res. 59:1999;4392-4399.
8. Vigushin D.M., Ali S., Pace P.E.et al. Trichostatin A is a histone deacetylase inhibitor with potent antitumor activity against breast cancer in vivo. Clin. Cancer Res. 7:2001;971-976.
9. Magnaghi-Jaulin L., Groisman R., Naguibneva I.et al. Retinoblastoma protein represses transcription by recruiting a histone deacetylase. Nature. 391:1998;601-605.
10. Zhang Y., Ng H.H., Erdjument-Bromage H., Tempst P., Bird A., Reinberg D. Analysis of the NuRD subunits reveals a histone deacetylase core complex and a connection with DNA methylation. Genes Dev. 13:1999;1924-1935.
11. Wang J-H., Hoshino T., Redner R.L., Kajigaya S., Liu J.M. ETO, fusion parent in t(8:21) acute myeloid leukaemia, represses transcription by interaction with the human N-coR/mSin3/HDAC1 complex. Proc. Natl. Acad. Sci. USA. 95:1998;10860-19865.
12. Wang J-H., Avitahl N., Cariappa A.et al. Aiolos regulates B cell activation and maturation to effector state. Immunity. 9:1998;543-553.
13. Sun L., Heerema N., Crotty L.et al. Expression of dominant-negative and mutant isoforms of the antileukemic transcription factor Ikaros in infant acute lymphoblastic leukemia. Proc. Natl. Acad. Sci. USA. 96:1999;680-685.
14. Sun L., Crotty M.L., Sensel M.et al. Expression of dominant-negative Ikaros isoforms in T-cell acute lymphoblastic leukemia. Clin. Cancer Res. 5:1999;2112-2120.
15. Winandy S., Wu P., Georgopoulos K. A dominant mutation in the Ikaros gene leads to rapid development of leukaemia and lymphoma. Cell. 83:1995;289-299.
16. Banerjee S., Bennion G.R., Goldberg M.W., Allen T.D. ATP dependent histone phosphorylation and nucleosome assembly in a human cell-free extract. Nucl. Acids Res. 19:1991;5999-6006.
17. Bonner W.M., West M.H.P., Stedman J.D. Two-dimensional gel analysis of histones in acid extracts of nuclei, cells, and tissues. Eur. J. Biochem. 109:1980;19-23.
18. Van Lint C., Emiliani S., Verdin E. The expression of a small fraction of cellular genes is changed in response to histone hyperacetylation. Gene Exp. 5:1996;245-253.
19. Yoshida M., Kijima M., Akita M., Beppu T. Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by Trichostatin A. J. Biol. Chem. 265:1990;17174-17179.
20. He T.C., Sparks A.B., Rago C.et al. Identification of c-MYC as a target of the APC pathway. Science. 281:1998;1438-1441.
21. Collins S., Groudine M. Amplification of endogenous myc-related DNA sequences in a human myeloid leukaemia cell line. Nature. 298:1982;679-681.
22. Kobayashi A., Yamagiwa H., Hoshino H.et al. A combinatorial code for gene expression generated by transcription factor Bach2 and MAZR (MAZ-related factor) through the BTB/POZ domain. Mol. Cell Biol. 20:2000;1733-1746.
23. Bao J., Zervos A.S. Isolation and characterization of Nmi, a novel partner of Myc proteins. Oncogene. 12:1996;2171-2176.
24. Jong M.T., Gray T.A., Ji Y.et al. A novel imprinted gene, encoding a RING zinc-finger protein, and overlapping antisense transcript in the Prader-Willi syndrome critical region. Hum. Mol. Genet. 8:1999;783-793.
25. Nicholls R.D., Saitoh S., Horsthemke B. Imprinting in Prader-Willi and Angelman syndromes. Trends Genet. 14:1998;194-200.
26. Wutz A., Smrzka O.W., Schweifer N., Schellander K., Wagner E.F., Barlow D.P. Imprinted expression of the Igf2r gene depends on an intronic CpG island. Nature. 389:1997;745-749.
27. Marks P.A., Richon V.M., Breslow R., Rifkind R.A. Histone deacetylase inhibitors as new cancer drugs. Curr. Opin. Oncol. 13:2001;477-483.
28. Kitabayashi I., Ida K., Morohoshi F.et al. The AML1-MTG8 leukemic fusion protein forms a complex with a novel member of the MTG8(ETO/CDR) family, MTGR1. Mol. Cell Biol. 18:1998;846-858.
29. Calabi F., Cilli V. CBFA2T1, a gene rearranged in human leukaemia, is a member of a multigene family. Genomics. 52:1998;332-341.
30. Sauvageau G., Lansdorp P.M., Eaves C.J.et al. Differential expression of homeobox genes in functionally distinct CD34+ subpopulations of human bone marrow cells. Proc. Natl. Acad. Sci. USA. 91:1994;12223-12227.
31. Rajeevan M.S., Ranamukhaarachchi D.G., Vernon S.D., Unger E.R. Use of real-time quantitative PCR to validate the results of cDNA array and differential display PCR technologies. Methods. 25:2001;443-451.